Hazy lesion in a ventricular tachycardia patient: stents or drugs?

Demin Liu1, Xiaoxue Jin1, Guoqiang Gu2

  • 1Department of Cardiology, Second Hospital of Hebei Medical University, Shijiazhuang, 050000, Hebei, People's Republic of China.

Insights

Intravascular ultrasound (IVUS) offers superior guidance for complex percutaneous coronary intervention (PCI) compared to coronary angiography. This case study demonstrates successful PCI optimization using IVUS for a patient with left anterior descending artery stenosis.

Area of Science:

  • Cardiovascular Imaging and Intervention
  • Interventional Cardiology

Background:

  • Coronary artery disease necessitates precise lesion assessment for optimal percutaneous coronary intervention (PCI).
  • Intravascular ultrasound (IVUS) provides detailed cross-sectional imaging of coronary arteries, complementing traditional angiography.
  • Ventricular tachycardia can be a symptom of significant coronary artery disease.

Purpose of the Study:

  • To illustrate the utility of IVUS in guiding and optimizing PCI for complex coronary lesions.
  • To report a successful PCI case where IVUS identified significant stenosis not fully characterized by angiography.

Main Methods:

  • Coronary angiography was performed to initially assess the left anterior descending artery (LAD).
  • Intravascular ultrasound (IVUS) was utilized for detailed lesion characterization, including stenosis severity.
  • Percutaneous coronary intervention (PCI) with a drug-eluting stent was performed based on IVUS findings.

Main Results:

  • Coronary angiography showed a hazy lesion in the proximal LAD.
  • IVUS revealed a significant 73% segment stenosis in the proximal LAD.
  • Successful implantation of a 3.5x21 mm drug-eluting stent resulted in an excellent angiographic outcome.

Conclusions:

  • IVUS is a valuable tool for optimizing complex PCI, providing critical information beyond standard angiography.
  • Accurate assessment with IVUS can lead to improved procedural success and patient outcomes in interventional cardiology.

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
159
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
44
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
199
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
65
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
68
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
94